The sterilization technologies market is projected to reach US$ 10,425.38 million by 2031 from US$ 6,459.28 million in 2024. The market is estimated to register a CAGR of 6.9% during 2025-2031. Major factors driving the market growth include the rising incidence of hospital-acquired infections (HAIs), stringent regulatory standards for sterilization and infection control, and a shift toward reprocessing, outsourcing, and efficient sterilization workflows are propelling the adoption of sterilization technologies. Further, expansion in emerging markets will likely boost the market during the forecast period. However, high capital investment and operating costs, regulatory, safety, and environmental challenges, material compatibility & technology limitations are among the market deterrents.

Regulatory measures are designed to deliver safe and effective medical devices (MDs) and healthcare consumables (HCCs). International standards such as ISO 11135:2025 for ethylene oxide (ETO) sterilization and ISO 22441:2022 for low-temperature vaporized hydrogen peroxide provide detailed guidance on development, validation, and operational control for sterilization processes in both industrial and hospital settings.

The U.S. Food and Drug Administration (FDA) recognize standard consensus documents, such as ISO 11135 and ISO 22441, as references that facilitate the device approval process when these techniques are proposed. Moreover, the FDA's Center for Devices and Radiological Health (CDRH) has updated its Recognized Consensus Standards repository by fully acknowledging ISO 22441:2022, thereby endorsing the use of low-temperature vaporized hydrogen peroxide as an alternative sterilization approach.

Approximately 4.3 million hospital patients in the EU and EEA altogether contract at least one healthcare-associated infection annually. Thus, stringent requirements for sterilization are necessary for lessening the HAI risks.

Continuously evolving standards reflect the advancement of disinfection innovations and the growing concern for patient safety issues. The emergence of new standards-such as the forthcoming ISO/DIS 11135:2025-emphasizes the market's serious commitment to optimizing sterilization procedures and ensuring that product safety and performance requirements are met.

Beyond significantly enhancing patient safety by preventing infections through effective sterilization measures, these standards also function as regulatory checkpoints, ensuring healthcare products comply with local legislative requirements and facilitating smoother market access.

The comparative company analysis evaluates and categorizes the Sterilization Technologies market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Sterilization Technologies market. The key market players are STERIS plc, 3M Company, Belimed AG, Advanced Sterilization Products (ASP), Sotera Health, Amcor Plc, Getinge AB, and Matachana Group

In terms of method, the Sterilization Technologies market is bifurcated into ethylene oxide, chlorine dioxide, gamma ray, electron beam, autoclave steam, and others. The ethylene oxide segment held a larger market share in 2024, owing to its popularity and effectiveness for the sterilization of complex medical devices that are sensitive to heat and moisture, that is leading the sterilization technologies market.

Based on end user, the sterilization technologies market is categorized into medical device companies, pharmaceutical & biotechnology companies, hospital and clinics, laboratories, and others. The medical device companies segment held a larger share of the market in 2024. Within the sterilization technologies market for medical device companies, manufacturers are the key players who largely determine the emergence of new equipment, the selection of new modalities, and the requirements of compliance. Recent developments have uncovered the major trends for instance the device-makers are collaborating with sterilization technology providers or contract sterilization companies to obtain fully validated and future-proof sterilization pathways.

Companies operating in the Sterilization Technologies market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key Sterilization Technologies market players are listed below.

In September 2025, SteelcoBelimed, a global leader in decontamination technology and a member of the Miele Group, has entered into a strategic joint venture with iM Med, creating a powerful new force in the healthcare decontamination sector. The SteelcoBelimed and iM Med partnership creates a powerhouse platform that transcends traditional industry boundaries. This partnership creates one of the largest comprehensive service networks in the industry, with iM Med's technical teams supporting over 1,000 assets nationwide across the United Kingdom.

In May 2025, MATACHANA launched the NEW S1000 STEAM STERILIZER, a device designed to redefine hospital sector standards. This development is the result of firm commitment to technological innovation, commitment to caring for the environment, and the durability of devices, guaranteeing a product that will accompany our customers throughout its useful life, with exceptional performance.

In October 2024, Belimed, a leading provider of medical instrument sterilization and disinfection solutions, and VERDA, a renowned expert in water quality management, announced a partnership between the two organizations. This collaboration aims to provide healthcare facilities with comprehensive solutions to meet the stringent requirements of the ANSI/AAMI ST108 standard for water quality management.